Company Analysis Sun Pharmaceutical Industries Limited
1. Summary
Advantages
- Dividends (0.8206%) are higher than the sector average (0.6496%).
- The stock's return over the last year (31.42%) is higher than the sector average (-42.81%).
- Current debt level 3.33% is below 100% and has decreased over 5 years from 15.14%.
- The company's current efficiency (ROE=16.01%) is higher than the sector average (ROE=3.69%)
Disadvantages
- Price (1786.05 βΉ) is higher than fair price (555.5 βΉ)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
Sun Pharmaceutical Industries Limited | Healthcare | Index | |
---|---|---|---|
7 days | -5.8% | -6.2% | -0.6% |
90 days | -8% | -5.6% | -4.8% |
1 year | 31.4% | -42.8% | 7.2% |
SUNPHARMA vs Sector: Sun Pharmaceutical Industries Limited has outperformed the "Healthcare" sector by 74.23% over the past year.
SUNPHARMA vs Market: Sun Pharmaceutical Industries Limited has outperformed the market by 24.2% over the past year.
Stable price: SUNPHARMA is not significantly more volatile than the rest of the market on "Bombay Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SUNPHARMA with weekly volatility of 0.6041% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (1786.05 βΉ) is higher than the fair price (555.5 βΉ).
Price is higher than fair: The current price (1786.05 βΉ) is 68.9% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (40.29) is lower than that of the sector as a whole (56.11).
P/E vs Market: The company's P/E (40.29) is lower than that of the market as a whole (43.66).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (5.75) is lower than that of the sector as a whole (8.08).
P/BV vs Market: The company's P/BV (5.75) is lower than that of the market as a whole (6.15).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (8.08) is lower than that of the sector as a whole (17.79).
P/S vs Market: The company's P/S indicator (8.08) is lower than that of the market as a whole (8.67).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (19.65) is higher than that of the sector as a whole (4.22).
EV/Ebitda vs Market: The company's EV/Ebitda (19.65) is higher than that of the market as a whole (15.13).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 30.87% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (30.87%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-17.15%).
5.4. ROE
ROE vs Sector: The company's ROE (16.01%) is higher than that of the sector as a whole (3.69%).
ROE vs Market: The company's ROE (16.01%) is higher than that of the market as a whole (-0.3088%).
5.5. ROA
ROA vs Sector: The company's ROA (11.52%) is higher than that of the sector as a whole (3.44%).
ROA vs Market: The company's ROA (11.52%) is higher than that of the market as a whole (7.53%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (18.19%) is higher than that of the sector as a whole (11.26%).
ROIC vs Market: The company's ROIC (18.19%) is higher than that of the market as a whole (16.2%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 0.8206% is higher than the average for the sector '0.6496%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.8206% has been steadily paid over the past 7 years, DSI=0.93.
Dividend growth: Company's dividend yield 0.8206% has been growing over the last 5 years. Growth over 5 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (30.26%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription